insights_auto
Miks on ALMKT langenud? 2,74%?
Uurige põhjalikumaltchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
arrow_downward
−2,74%(−0,0026) 1 p
12. nov, 17:35:12 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALMKT põhistatistika genereerimine…
Ava
0,10 €
Kõrge
0,10 €
Madal
0,09 €
Turu kapit.
19,00 mln
Keskm. maht
545,11 tuh
Maht
189,93 tuh
Hinna ja tulu suhe
0,79
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Ava
0,10 €
Kõrge
0,10 €
Madal
0,09 €
Turu kapit.
19,00 mln
Keskm. maht
545,11 tuh
Maht
189,93 tuh
Hinna ja tulu suhe
0,79
52 näd kõrgeim
0,23 €
52 näd madalaim
0,07 €
Aktsiatulu
0,12 €
Käibivad aktsiad
195,26 mln
Töötajate arv
56
Uudised
Veebiallikatest ja uudistepartneritelt
Foreign Policy Journal
·
21 minuti eest
AST SpaceMobile (NASDAQ: ASTS) Burns Through Cash At A Pace That Dwarfs Its Revenue Growth, Raising Questions About Its Lofty Valuation
www.marketscreener.com
·
9 minuti eest
System1 Announces Intention to Voluntarily Delist from The New York Stock Exchange
TradingView
·
3 tunni eest
Nine Listings Transfer to the NYSE in 2026 Amounting to $500B in Market Cap
The Motley Fool
·
2 tunni eest
The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility.
Profiil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Teave üksuse Mauna Kea Technologies SA kohta
TegevjuhtSacha Loiseau
Töötajad56
Asutatud2000
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitmaunakeatech.com